CN Stock MarketDetailed Quotes
600645 Vcanbio Cell & Gene Engineering Corp.,Ltd.
- 21.89
- +1.73+8.58%
Market Closed Sep 30 15:00 CST
10.24BMarket Cap93.95P/E (TTM)
21.92High20.43Low292.34KlotVolume20.88Open20.16Pre Close623.24MTurnover6.25%Turnover Ratio96.43P/E (Static)467.95MShares21.9952wk High2.84P/B10.24BFloat Cap12.8852wk Low22.18Limit Up467.77MShs Float79.58Historical High18.14Limit Down7.39%Amplitude1.23Historical Low--Dividend TTM21.32Avg Price118.11KlotAsk--Div YieldTTM100Lot Size155.43KlotBid
Vcanbio Cell & Gene Engineering Corp.,Ltd. Key Stats
EPS
According to the latest financial report of Vcanbio Cell & Gene Engineering Corp.,Ltd., the latest earnings per share (TTM) for the company is 0.18. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: CNY
Cumulative Quarterly
Loading...
BVPS
Analyzing a company's fundamentals? Check out Vcanbio Cell & Gene Engineering Corp.,Ltd.'s latest financial report to see how much their book value per share (BVPS) is currently at 7.71.
Currency: CNY
Cumulative Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Vcanbio Cell & Gene Engineering Corp.,Ltd. shows that the company's current ratio is 1.67, indicating healthy liquidity.
Currency: CNY
Cumulative Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Vcanbio Cell & Gene Engineering Corp.,Ltd., the quick ratio is 1.49, indicating that the company can meet its short-term debt obligations.
Currency: CNY
Cumulative Quarterly
Loading...
ROE
Want to learn more about the financial health of Vcanbio Cell & Gene Engineering Corp.,Ltd.? The latest ROE figure is 2.34%, indicating that the company has stable profitability.
Currency: CNY
Cumulative Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Vcanbio Cell & Gene Engineering Corp.,Ltd., the total asset return on investment (ROA) is 1.61%.
Currency: CNY
Cumulative Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Vcanbio Cell & Gene Engineering Corp.,Ltd.'s latest financial report to see how their gross margin is doing - currently at 69.06%.
Currency: CNY
Cumulative Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Vcanbio Cell & Gene Engineering Corp.,Ltd., the net profit margin is 10.73%, which is a good sign for its profitability.
Currency: CNY
Cumulative Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data